Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8880886 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
Condition: Prostatic Hyperplasia
Interventions: Drug: BONT-A intra-prostatic injection;   Drug: Optimized medical BPH treatment

Indicates status has not been verified in more than two years